Site icon pharmaceutical daily

Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Amblyopia
Global Clinical Trials Review, H2, 2018”
clinical trials has
been added to ResearchAndMarkets.com’s offering.

Amblyopia Global Clinical Trials Review, H2, 2018″ provides an overview
of Amblyopia clinical trials scenario. This report provides top line
data relating to the clinical trials on Amblyopia. Report includes an
overview of trial numbers and their average enrollment in top countries
conducted across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database – Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.

Scope

Reasons to Buy

Key Topics Covered:

  1. Report Guidance
  2. Clinical Trials Report Coverage
  3. Clinical Trials by Region
  4. Clinical Trials and Average Enrollment by Country
  5. Top Countries Contributing to Clinical Trials in Asia-Pacific
  6. Top Countries Contributing to Clinical Trials in Europe
  7. Top Countries Contributing to Clinical Trials in North America
  8. Top Countries Contributing to Clinical Trials in Middle East and Africa
  9. Clinical Trials by G7 Countries: Proportion of Amblyopia to
    Ophthalmology Clinical Trials
  10. Clinical Trials by Phase in G7 Countries
  11. Clinical Trials in G7 Countries by Trial Status
  12. Clinical Trials by E7 Countries: Proportion of Amblyopia to
    Ophthalmology Clinical Trials
  13. Clinical Trials by Phase in E7 Countries
  14. Clinical Trials in E7 Countries by Trial Status
  15. Clinical Trials by Phase
  16. In Progress Trials by Phase
  17. Clinical Trials by Trial Status
  18. Clinical Trials by End Point Status
  19. Subjects Recruited Over a Period of Time
  20. Clinical Trials by Sponsor Type
  21. Prominent Sponsors
  22. Top Companies Participating in Amblyopia Therapeutics Clinical Trials
  23. Prominent Drugs
  24. Clinical Trial Profile Snapshots
  25. Appendix

Companies Mentioned

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/2d325w/global_amblyopia?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials
, Optical

Exit mobile version